Our tools

Treatments & Peptide Therapy

Treatment options guided by clinical evaluation.

RTF offers a range of medical and supportive interventions that may be incorporated into an individualized care plan. Each recommendation considers the patient's clinical findings, treatment suitability, potential risks, and available evidence.

Treatment areas

Tools within the RTF system.

Diagnostics & evaluation

  • Biomarkers / Diagnostics
  • Hormone Evaluation
  • Movement Assessment

Medical therapies

  • Peptide Therapy
  • GLP-1 / Metabolic Support
  • Sexual Health Support
  • Mental Performance Support

Supportive & regenerative therapies

  • PRP / Regenerative Treatments
  • IV Therapy
  • Micronutrients
Peptide therapy

Peptide therapy at RTF

RTF protocol

Peptide therapy uses short chains of amino acids that act as signaling molecules in the body.

At RTF, peptide therapy is not treated as a trend or a quick fix. It is considered within a broader medical protocol after assessment, health history review, and clinical evaluation.

Protocol areas

  • Recovery & Repair
  • Weight & Metabolic Health
  • Sexual Health & Vitality
  • Mental Performance
  • Skin, Hair & Tissue Quality
  • Advanced Performance Support

Peptides and medications we may consider

Availability and suitability are confirmed by the medical team after evaluation. Not every option is appropriate for every person.

  • GLP-1 medications
  • PT-141 / Bremelanotide
  • BPC-157
  • TB-500
  • GHK-Cu
  • Thymosin alpha-1
  • MOTS-c
  • CJC-1295 with DAC
  • Ipamorelin
  • Tesamorelin
  • IGF-1 LR3
  • KPV
  • GHRP

Personalized. Monitored. Clinically guided.

Protocols are individualized after consultation and review of medical history, goals, risk factors, potential contraindications, and clinical context. Bloodwork and periodic monitoring may be recommended. Some therapies may involve off-label use and are only recommended when clinically appropriate.

Clinical & regulatory transparency

Clear context before treatment.

RTF believes patients should understand the clinical and regulatory context of any treatment being considered.

Some medications have FDA-approved uses for specific indications. Others may be used in wellness, longevity, regenerative, or performance contexts with varying levels of evidence, regulatory status, and clinical experience.

FDA approval status depends on the specific medication, formulation, route, indication, and use case. A treatment that is FDA-approved for one condition may not be FDA-approved for another use.

CategoryExamples
FDA-approved medications with specific approved usesGLP-1 medications; PT-141 / Bremelanotide
Peptides under FDA or compounding-related reviewBPC-157; TB-500; GHK-Cu; Thymosin alpha-1; MOTS-c; KPV
Used in wellness or longevity contexts with emerging or limited evidenceCJC-1295 with DAC; Ipamorelin; Tesamorelin; IGF-1 LR3; GHRP; additional peptide protocols as appropriate

Review status is not the same as FDA approval. Evidence, approval status, and clinical fit vary by treatment, and your medical team will explain the context of anything considered for your protocol.

Start Your Assessment